Literature DB >> 6360892

Isolation and characterization of the outer membrane and lipopolysaccharide from Eikenella corrodens.

A Progulske, S C Holt.   

Abstract

The chemical composition of the outer membrane fractions (OMFs) of Eikenella corrodens strains 23834 and 470 as well as the strain 23834 lipopolysaccharide (LPS) was determined. The OMFs were obtained by Triton X-100 treatment of the heavier membrane fraction from sucrose density centrifugation of the total membrane fraction. The resulting OMFs of strains 23834 and 470, free of cytoplasmic membrane components, were found to contain 69.6 and 75.0% (wt/wt) protein, 4.8 and 9.2% lipid, 4.6 and 4.7% carbohydrate, and 2.0 and 4.6% muramic acid, respectively. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis both OMFs contained one major peptide determined to be 33,500 daltons for the strain 23834 OMF, and 37,500 daltons for the strain 470 OMF. Analysis of the OMF fatty acids revealed hexadecanoic, hexadecenoic, octadecenoic, and lesser amounts of octadecanoic acids. Transmission electron microscopic examination of the OMFs revealed typical large sheets of membrane. Structures (10 nm in diameter) resembling pores were also evident. The E. corrodens LPS was found to be composed of 34.5% (wt/wt) carbohydrate and 25.0% lipid A. Only minute amounts of 2-keto-3-deoxyoctonate and heptose could be detected. Fatty acid analysis revealed primarily octadecanoic and hexadecanoic acids, with lesser amounts of octadecenoic acid. No hydroxy fatty acids were detected. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis showed the E. corrodens LPS to resemble other smooth-type LPSs. Transmission electron microscopic examination revealed a vesicle-like morphology. The E. corrodens LPS appears not to be a "classical," i.e., enteric, type of LPS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360892      PMCID: PMC263405          DOI: 10.1128/iai.43.1.166-177.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.

Authors:  O Westphal
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Mechanism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane.

Authors:  M J Osborn; J E Gander; E Parisi; J Carson
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Infections in children caused by the HB group of bacteria.

Authors:  J M Kaplan; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Peptidoglycan-associated outer membrane proteins in gammegatine bacteria.

Authors:  B Lugtenberg; H Bronstein; N van Selm; R Peters
Journal:  Biochim Biophys Acta       Date:  1977-03-17

Review 7.  Microbial surfaces in relation to pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1977-06

8.  Separation and characterization of the outer membrane of Pseudomonas aeruginosa.

Authors:  T Mizuno; M Kageyama
Journal:  J Biochem       Date:  1978-07       Impact factor: 3.387

9.  Eikenella corrodens isolated in oral infections of dental origin.

Authors:  A D Goodman
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1977-07

10.  Biological and chemical characterization of endotoxin from Capnocytophaga sputigena.

Authors:  R H Stevens; M N Sela; W P McArthur; A Nowotny; B F Hammond
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more
  10 in total

1.  Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus.

Authors:  G I Perez; J A Hopkins; M J Blaser
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

2.  Structures and sugar compositions of lipopolysaccharides isolated from seven Actinobacillus pleuropneumoniae serotypes.

Authors:  W Byrd; S Kadis
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Chemical and biological characterization of the lipopolysaccharide of the oral pathogen Wolinella recta ATCC 33238.

Authors:  J Gillespie; S T Weintraub; G G Wong; S C Holt
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Sensitivity of Capnocytophaga species to bactericidal properties of human serum.

Authors:  M E Wilson; R Burstein; J T Jonak-Urbanczyk; R J Genco
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Hemagglutinating activity of lipopolysaccharides from subgingival plaque bacteria.

Authors:  K Okuda; T Kato
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells.

Authors:  C B Huang; K A Emerson; O A Gonzalez; J L Ebersole
Journal:  Oral Microbiol Immunol       Date:  2009-10

7.  Biological activities of Eikenella corrodens outer membrane and lipopolysaccharide.

Authors:  A Progulske; R Mishell; C Trummel; S C Holt
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Extraction, purification, and characterization of major outer membrane proteins from Wolinella recta ATCC 33238.

Authors:  W L Kennell; S C Holt
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.

Authors:  T Kato; I Takazoe; K Okuda
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Lipopolysaccharide characteristics of pathogenic campylobacters.

Authors:  G I Perez Perez; M J Blaser
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.